|
| Newsletter 1 | Junio 2020 |
|
|
Este es un aporte de la Vicerrectoría de Investigación y Doctorado para dar a conocer cómo la comunidad científica y académica internacional está abordando el Covid-19.
|
|
|
|
|
|
| |
|
|
|
Principal Research Publication
|
|
|
|
|
|
|
|
|
|
Introduction: At the end of March, 2020, rapid tests detecting the presence of antiviral IgM and IgG antibodies against SARS-CoV-2 virus were introduced in Hungary for the identification of SARS-Co...
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COVID-19 is a new zoonotic disease caused by the SARS-CoV-2 virus. Since its emergence in Wuhan City, China, the virus has rapidly spread across the globe causing calamitous health, economic and socie...
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
 
Dirección de Innovación y Transferencia Tecnológica
Vicerrectoría de Investigación y Doctorado - Universidad Andrés Bello ®
|
|
|
| |
|
|
|
|
.jpg){kind=logo}
Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Partner to Develop a Coronavirus (COVID-19) Vaccine using ChaESARTM Technology
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection